One month of rifapentine plus isoniazid to prevent HIV-related Tuberculosis

by Susan Swindells, Ritesh Ramchandani, Amita Gupta, Constance A. Benson, Jorge Leon-Cruz, Noluthando Mwelase, Marc A. Jean Juste, Javier R. Lama, Javier Valencia, Ayotunde Omoz-Oarhe, Khuanchai Supparatpinyo, Gaerolwe Masheto, Lerato Mohapi, Rodrigo O. Da Silva Escada, Sajeeda Mawlana, Peter Banda, Patrice Severe, James Hakim, Cecilia Kanyama, Deborah Langat, Laura Moran, Janet Andersen, Courtney V. Fletcher, Eric Nuermberger, Richard E. Chaisson
Published 2019

Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study

by Beatriz Grinsztejn, Michael D. Hughes, Justin Ritz, Robert Salata, Peter Mugyenyi, Evelyn Hogg, Linda Wieclaw, Robert Gross, Catherine Godfrey, Sandra W. Cardoso, Aggrey Bukuru, Mumbi Makanga, Sharlaa Faesen, Vidya Mave, Beatrice Wangari Ndege, Sandy Nerette Fontain, Wadzanai Samaneka, Rode Secours, Marije van Schalkwyk, Rosie Mngqibisa, Lerato Mohapi, Javier Valencia, Patcharaphan Sugandhavesa, Esmelda Montalban, Anchalee Avihingsanon, Breno R. Santos, Nagalingeswaran Kumarasamy, Cecilia Kanyama, Robert T. Schooley, John W. Mellors, Carole L. Wallis, Ann C. Collier, B. Grinsztejn, P. N. Mugyenyi, A. Collier, R. Salata, C. Godfrey, E. Hogg, M. Hughes, J. Ritz, L. Wieclaw, T. Sise, J. W. Mellors, C. Wallis, C. V. Fletcher, M. Gandhi, R. Gross, R. T. Schooley, R. Walensky, M. van Schalkwyk, S. Faesen, R. Mngqibisa, J. Valencia, E. Montalban, N. Kumarasamy, C. Kanyama, S. W. Cardoso, B. R. Santos, B. Mansfield, H. Mugerwa, B. W. Ndege, R. Secours, W. Samaneka, D. Kadam, V. Mave, M. Makanga, S. N. Fontain, P. Sugandhavesa, A. Avihingsanon, L. Nakibuuka, H. Nassolo, P. Anthony, V. Kulkarni, M. Nsubuga, J. van Wyk, J. Rooney, Y. van Delft, R. Leavitt, R. Luk, A. Benns, L. Hovind, A. Shahkolahi
Published 2019